IPO · 2026-01-30

Anti-Dilution Provisions in Pre-IPO Financing: Weighted Average vs Full Ratchet Calculation Differences

The Hong Kong Stock Exchange’s (HKEX) 2025 consultation on proposed changes to the Listing Rules regarding pre-IPO investments, expected to be codified in a new Chapter 11A by mid-2026, has placed anti-dilution provisions under unprecedented scrutiny. The SFC’s 2024 thematic review of sponsor work noted that 23% of examined IPO prospectuses contained anti-dilution clauses in pre-IPO subscription agreements that the regulator deemed potentially misleading to public investors regarding the true cost of capital (SFC, 2024). For CFOs of companies targeting a Main Board listing within 18 months, the choice between a weighted-average and a full-ratchet anti-dilution mechanism is no longer a purely mathematical negotiation point—it is a structural decision that directly impacts the sponsor’s ability to certify the company’s financial history under HKEX Listing Rule 11.06. A miscalculated provision can trigger a mandatory downward adjustment to the IPO price, force a re-audit of historical share-based compensation, or, in extreme cases, scuttle the listing timeline by requiring a full re-negotiation of the pre-IPO round. This article dissects the calculation mechanics, regulatory landmines, and practical structuring options for these two dominant anti-dilution models.

The Mechanics of Dilution Protection in Pre-IPO Rounds

Anti-dilution provisions in pre-IPO financing are contractual mechanisms that adjust the conversion price of convertible instruments—typically convertible notes (CNs) or convertible preferred shares—when the issuer subsequently issues equity at a price lower than the original conversion price. This is distinct from simple dilution, which occurs when new shares are issued at any price. The provision recalibrates the investor’s economic stake to compensate for the value impairment caused by a “down round.”

Weighted-Average: The Market Standard

The weighted-average formula is the prevailing standard in Hong Kong pre-IPO financings, used in an estimated 85% of Series B and later-stage rounds involving Hong Kong-incorporated or Cayman Islands-domiciled issuers targeting an HKEX listing, according to data from the Hong Kong Venture Capital and Private Equity Association (HKVCA) 2024 Deal Terms Survey. The formula calculates a new conversion price by factoring in both the price and the volume of the new issuance relative to the total shares outstanding.

The standard formula is: New Conversion Price = (Old Conversion Price × (A + B)) / (A + C), where A = the number of outstanding shares on a fully diluted basis immediately before the new issuance, B = the number of shares that would have been issued at the old conversion price for the total consideration of the new issuance, and C = the actual number of shares issued in the new issuance.

Example Calculation: A pre-IPO investor holds a CN with a conversion price of HKD 10.00 per share. The issuer has 100,000,000 shares outstanding on a fully diluted basis (A). The issuer then conducts a down round, issuing 20,000,000 new shares (C) at HKD 8.00 per share, raising HKD 160,000,000. Under the weighted-average formula, B = HKD 160,000,000 / HKD 10.00 = 16,000,000 shares. The new conversion price = (HKD 10.00 × (100,000,000 + 16,000,000)) / (100,000,000 + 20,000,000) = HKD 9.67. The investor’s conversion price drops from HKD 10.00 to HKD 9.67, a 3.3% adjustment, reflecting the fact that the down round was only 20% of the existing base.

Full Ratchet: The Aggressive Protector

The full ratchet is a binary, zero-sum mechanism. If the issuer issues any equity at a price lower than the investor’s original conversion price, the investor’s conversion price is automatically reset to that lower price, regardless of the volume of the new issuance. This is almost universally found in convertible note financings for early-stage biotech companies or distressed pre-IPO situations where the investor has significant leverage.

Example Calculation: Using the same fact pattern—original conversion price HKD 10.00, new issuance of 20,000,000 shares at HKD 8.00—a full ratchet resets the investor’s conversion price to exactly HKD 8.00. The investor’s conversion price drops by 20%. If the full ratchet is applied to a “pay-to-play” variant, the adjustment only applies if the investor does not participate pro-rata in the new round. If the investor participates, the full ratchet is waived or replaced by a weighted-average adjustment.

Regulatory and Accounting Implications for HKEX Listing Candidates

The choice between these two mechanisms carries direct consequences for the issuer’s financial statements and the sponsor’s ability to satisfy the HKEX’s suitability requirements under Listing Rule 8.04.

Under Hong Kong Financial Reporting Standard (HKFRS) 2, a full ratchet provision in a convertible instrument is classified as a derivative liability rather than equity, because the conversion price is not fixed. The issuer must fair-value this derivative at each reporting date, with changes in fair value flowing through the profit and loss statement. A weighted-average provision, by contrast, is typically treated as an equity instrument with a fixed-for-fixed conversion price, provided the adjustment formula is not “too broad” as defined under HKAS 32. The SFC’s 2024 sponsor review specifically flagged that 12% of reviewed prospectuses had misclassified convertible instruments with full ratchets as equity, leading to a material restatement of historical EPS figures. For a company targeting an HKEX Main Board listing, a restatement of EPS for the three most recent financial years under Listing Rule 4.04 can delay the filing of the A1 application by at least four to six months.

HKEX Listing Rule 10.07 imposes a six-month lock-up on controlling shareholders post-listing. However, the SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (paragraph 17.6) requires sponsors to conduct “reasonable due diligence” on all pre-IPO investor rights that could affect the public’s perception of the company’s valuation. A full ratchet provision that triggers a conversion price adjustment immediately before the IPO price is finalised creates a scenario where the sponsor cannot certify that the IPO price is “fair and reasonable” under Listing Rule 9.11. The sponsor must then either (a) negotiate a waiver of the full ratchet for the IPO round, (b) require the company to repurchase the instrument at a premium, or (c) disclose the potential adjustment in the prospectus, which the HKEX listing division may deem a “material uncertainty” requiring a qualified sponsor opinion.

Structuring Anti-Dilution Provisions for a Clean Listing Path

CFOs and their legal advisors can employ several structuring techniques to mitigate the regulatory drag of anti-dilution provisions while preserving investor protections.

The “IPO Exclusion” Clause

The most common structural fix is to include an explicit exclusion for the IPO itself from the anti-dilution calculation. The clause states that the issuance of shares in the IPO—whether at a price lower than the investor’s conversion price or not—does not trigger any anti-dilution adjustment. This is standard practice in Hong Kong pre-IPO rounds documented by the Hong Kong Law Society’s 2023 Model Investment Documents. Without this clause, a full ratchet could theoretically reset the pre-IPO investor’s conversion price to the IPO price, rendering the investor’s economic stake indistinguishable from a public investor’s and defeating the purpose of the pre-IPO round.

The “Broad-Based” Weighted-Average Variant

A “broad-based” weighted-average formula includes all outstanding shares, options, warrants, and convertible instruments in the denominator (A), while a “narrow-based” formula excludes some of these. The broad-based variant is the least dilutive to existing shareholders and is the default recommended by the HKVCA for pre-IPO rounds. It reduces the probability of a material EPS restatement because the adjustment is mathematically less extreme. For a company with 50,000,000 shares outstanding and 10,000,000 options, a narrow-based formula (using only 50,000,000 as A) would produce a new conversion price of HKD 9.33 in the earlier example, versus HKD 9.67 under the broad-based formula. The difference of HKD 0.34 per share can be material for EPS calculations.

The “Pay-to-Play” Full Ratchet

If a full ratchet is unavoidable—typically demanded by a lead investor providing a “rescue” round—a pay-to-play provision mitigates the damage. This clause requires the investor to participate pro-rata in the down round to retain the full ratchet protection. If the investor does not participate, the protection defaults to a weighted-average formula. This structure is recognised by the HKEX as a legitimate commercial term and does not automatically trigger a derivative liability classification under HKFRS 2, provided the investor’s participation obligation is substantive and enforceable. The SFC’s 2024 guidance on convertible instruments (SFC, 2024, paragraph 3.7) explicitly permits this structure as consistent with the “fixed-for-fixed” test.

Actionable Takeaways for Pre-IPO CFOs

Mandate a broad-based weighted-average formula in all convertible note and preferred share subscription agreements, and explicitly exclude the IPO from the calculation to avoid a derivative liability classification under HKFRS 2.
Require your sponsor to conduct a “stress test” of the anti-dilution provision against the lowest plausible IPO price in your valuation range, and document the impact on EPS for each of the three historical years under Listing Rule 4.04.
Negotiate a “pay-to-play” provision if a full ratchet is demanded by a lead investor; this preserves the protection for the investor while keeping the instrument off the profit and loss statement.
Disclose the anti-dilution provision in the prospectus’s “Risk Factors” and “Summary of Principal Terms” sections, with a clear numerical example of the adjustment, to satisfy the SFC’s Code of Conduct paragraph 17.6 requirements on material investor rights.
File the subscription agreement with the HKEX at the A1 submission stage, not at the hearing stage, to allow the listing division to pre-clear the anti-dilution mechanism under Listing Rule 9.11 before incurring the costs of the full application process.